Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Zhongke Meiling Cryogenics CoBJSE:920992 62 EV-to-FCF is 20.43 as of Aug. 17, 2026, which is 37% below its 10-year median of 32.34. GuruFocus rates BJSE:920992 with a GF Score™ of 62/100 and a GF Value™ of ¥13.38 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 406 Medical Devices & Instruments companies, Zhongke Meiling Cryogenics Co ranks better than 70.2% on this metric.
The historical rank and industry rank for Zhongke Meiling Cryogenics Co's EV-to-FCF or its related term are showing as below:
BJSE:920992'
s EV-to-FCF Range Over the Past 10 Years
Min: -49.74 Med: 32.34 Max: 775.56
Current: 15.89
During the past 13 years, the highest EV-to-FCF of Zhongke Meiling Cryogenics Co was 775.56. The lowest was -49.74. And the median was 32.34.
BJSE:920992's EV-to-FCF is ranked better than 70.2% of 406
companies
in the Medical Devices & Instruments industry
Industry Median: 25.2
vs BJSE:920992: 15.89
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Zhongke Meiling Cryogenics Co (BJSE:920992) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Zhongke Meiling Cryogenics Co's PE Ratio (TTM) for today is calculated as:
Zhongke Meiling Cryogenics Co's share price for today is ¥11.78.
Zhongke Meiling Cryogenics Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.186.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Zhongke Meiling Cryogenics Co EV-to-FCF Related Terms
Zhongke Meiling Cryogenics Co EV-to-FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BJSE:920992 vs ABT, SYK, MDT: EV-to-FCF Comparison
For the Medical Devices subindustry, Zhongke Meiling Cryogenics Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zhongke Meiling Cryogenics Co EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Zhongke Meiling Cryogenics Co's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Zhongke Meiling Cryogenics Co's EV-to-FCF falls into.
Zhongke Meiling Cryogenics Co's current Enterprise Value is ¥558.8 Mil.
Zhongke Meiling Cryogenics Co's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥27.4 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zhongke Meiling Cryogenics Co (BJSE:920992) has a EV-to-FCF of 20.43 as of Aug. 17, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Zhongke Meiling Cryogenics Co and its competitors. This is 37% below median its historical median of 32.34. According to the industry distribution chart, Zhongke Meiling Cryogenics Co ranks #121 out of 406 companies in the Medical Devices & Instruments industry, placing it in the top 29.8%.
Is Zhongke Meiling Cryogenics Co's EV-to-FCF too high?
Zhongke Meiling Cryogenics Co's current EV-to-FCF of 20.43 is 37% below median its 10-year median of 32.34. The Medical Devices & Instruments industry median EV-to-FCF is 25.20. Zhongke Meiling Cryogenics Co's value of 20.43 is 18.9% below this industry median. Based on the distribution chart, Zhongke Meiling Cryogenics Co ranks #121 out of 406 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Zhongke Meiling Cryogenics Co has a GF Score™ of 62/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Zhongke Meiling Cryogenics Co's EV-to-FCF compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Zhongke Meiling Cryogenics Co ranks #121 out of 406 companies for EV-to-FCF. This puts Zhongke Meiling Cryogenics Co in the upper half of its industry. The industry median EV-to-FCF is 25.20. Zhongke Meiling Cryogenics Co's value of 20.43 is 18.9% below this benchmark. While the company's 10-year median is 32.34 vs. the industry median of 25.20, Zhongke Meiling Cryogenics Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 25.20, based on 406 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Zhongke Meiling Cryogenics Co's current EV-to-FCF of 20.43 is 18.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Zhongke Meiling Cryogenics Co and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 25.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zhongke Meiling Cryogenics Co's current EV-to-FCF is 20.43, which is 37% below median its own 10-year median of 32.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhongke Meiling Cryogenics Co stock overvalued right now?
Based on GuruFocus' analysis, Zhongke Meiling Cryogenics Co (BJSE:920992) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥13.38, compared to a current price of ¥11.78 — trading 12% below its estimated fair value. The current EV-to-FCF is 20.43, which is 37% below median its 10-year median of 32.34 and 18.9% below the Medical Devices & Instruments industry median of 25.20. Zhongke Meiling Cryogenics Co's overall GF Score™ is 62/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Zhongke Meiling Cryogenics Co (BJSE:920992), the current EV-to-FCF is 20.43 as of Aug. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Zhongke Meiling Cryogenics Co (BJSE:920992) Overvalued in 2026?
Based on GuruFocus' analysis, Zhongke Meiling Cryogenics Co stock appears to be undervalued.
The current stock price of ¥11.78 is trading 12% below its estimated GF Value™ of ¥13.38.
GuruFocus considers Zhongke Meiling Cryogenics Co to be Modestly Undervalued.
Key valuation signals for BJSE:920992:
EV-to-FCF: 20.43 (37% below median its 10-year median of 32.34)
GF Value™: ¥13.38 vs. price of ¥11.78 (12% below fair value)
Industry Position: 18.9% below the Medical Devices & Instruments median (#121 of 406)
No single metric tells the full story. See the BJSE:920992 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Zhongke Meiling Cryogenics Co Ltd engages in research and development, production, and sales of biomedical cryogenic storage equipment. The company's main products include a lab / medical refrigerator and freezer, ultra-low temperature freezer, blood bank refrigerator, inventory rack/box, professional cold room, and bio-bank management.
62GF Score
Get the complete analysis for BJSE:920992
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BJSE:920992 has been successfully added to your 
